Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2022

Aug 18, 2022

35200_dirs_2022-08-18_07c3afae-7c6f-4073-81b5-24fefd72fbb5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-08-16

Reporting Person: Brandt Peter C. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-16 Common Stock P 105263 $1.90 Acquired 182473 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 105290 Indirect

Footnotes

F1: Includes 77,210 shares received as an annual annuity payment from the Reporting Person's GRAT. This transfer constitutes a mere change in the form of ownership and is exempt from reporting pursuant to Rule 16a-13.

F2: The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.